Literature DB >> 11888633

Fusidic acid resistance in Staphylococcus aureus isolates.

Erwin M Brown, Paul Thomas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888633     DOI: 10.1016/S0140-6736(02)07869-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  24 in total

1.  Fusidic acid cream for impetigo. Fusidic acid should be used with restraint.

Authors:  Erwin M Brown; Richard Wise
Journal:  BMJ       Date:  2002-06-08

2.  Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.

Authors:  T Norén; M Wullt; Thomas Akerlund; E Bäck; I Odenholt; L G Burman
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 3.  [Topical antibiotics in skin infections].

Authors:  D Thaçi; H Schöfer
Journal:  Hautarzt       Date:  2005-04       Impact factor: 0.751

4.  Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus.

Authors:  Silke Besier; Albrecht Ludwig; Volker Brade; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Interventions to reduce Staphylococcus aureus in the management of eczema.

Authors:  Susannah Mc George; Sanja Karanovic; David A Harrison; Anjna Rani; Andrew J Birnie; Fiona J Bath-Hextall; Jane C Ravenscroft; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2019-10-29

6.  A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.

Authors:  Alexander J O'Neill; Anders R Larsen; Anne S Henriksen; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 7.  Role of bacterial pathogens in atopic dermatitis.

Authors:  Yu-Tsan Lin; Chen-Ti Wang; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 8.667

8.  In vitro activity of CEM-102 (fusidic acid) against prevalent clones and resistant phenotypes of Staphylococcus aureus.

Authors:  D F Sahm; J Deane; C M Pillar; P Fernandes
Journal:  Antimicrob Agents Chemother       Date:  2013-06-17       Impact factor: 5.191

9.  Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms.

Authors:  Remco P Rietveld; Gerben ter Riet; Patrick J E Bindels; Jacobus H Sloos; Henk C P M van Weert
Journal:  BMJ       Date:  2004-06-16

Review 10.  Fusidic acid resistance in Staphylococcus aureus.

Authors:  D Dobie; J Gray
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.